MEETINGS - Protecting Biotechnological Inventions (Belgium) September 1998:
This article was originally published in Clinica
IBC Conferences will hold a meeting on Protecting Biotechnological Inventions on September 17-18 in Brussels. Discussion will focus on biotech patent drafting considerations in various countries including Japan and Australia; the impact of the EU biotech directive on the European Patent Office (EPO); latest practice developments at the EPO; implications of the biosafety protocol for commerce and research; and issues of enablement and definitiveness in the US. For more information contact IBC's UK office. Tel: +44 171 453 5492. Fax: +44 171 636 6858.
You may also be interested in...
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
Considerable value has been assigned to the companies developing coronavirus vaccines. Multiple suppliers and a met clinical need may erode much of that value after the pandemic.